Metabolic Syndrome and NASH: Risk for HCC

被引：0
|
作者：
不详
机构：
来源：
DIABETES STOFFWECHSEL UND HERZ | 2022年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [21] The paradox of immunotherapy in NASH-HCC
    Yao Peng
    Chi Chun Wong
    Jun Yu
    Signal Transduction and Targeted Therapy, 6
  • [22] Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC
    Tian, Yunhong
    Lyu, Huan
    He, Yunhong
    Xia, Yong
    Li, Jun
    Shen, Feng
    JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (04) : 615 - 623
  • [23] Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC
    Yunhong Tian
    Huan Lyu
    Yunhong He
    Yong Xia
    Jun Li
    Feng Shen
    Journal of Gastrointestinal Surgery, 2018, 22 : 615 - 623
  • [24] Nonalcoholic steatohepatitis (NASH) in adults with features of metabolic syndrome (MS)
    Aguilar-Urbano, Victor
    Pereda, Teresa
    Gonzalo-Marin, Juana
    Moreno-Mejias, Pedro
    Bercedo, Julio
    Verdugo, Jose
    Moya-Donoso, Francisco
    Fernandez-Cano, Francisco
    Rivas-Ruiz, Francisco
    Gandara-Adan, Norberto
    Navarro, J. M.
    HEPATOLOGY, 2013, 58 : 504A - 504A
  • [25] Are there any risks of NASH and hepatic fibrosis during metabolic syndrome?
    Dupuy, O
    Mennecier, D
    Mayaudon, H
    Bordier, L
    Le Berre, JP
    Bauduceau, B
    DIABETES & METABOLISM, 2006, 32 : S54 - S54
  • [26] NAFLD/NASH IN METABOLIC SYNDROME AND EARLY TYPE 2 DIABETES
    Byrne, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A5 - A6
  • [27] Metabolic syndrome can not predict histological NASH in patient with NAFLD
    Duseja, Ajay Kumar
    Thumburu, Kiran Kumar
    Das, Ashim
    Dhiman, R. K.
    Chawla, Y. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A238 - A238
  • [28] Myosteatosis is associated with early NASH in the context of obesity and metabolic syndrome
    Nachit, Maxime
    Vande Velde, Greetje
    Kwanten, Wilhelmus
    Thissen, Jean-Paul
    De Rudder, Maxime
    Schakman, Olivier
    Bouzin, Caroline
    Op De Beeck, Bart
    Van Gaal, Luc
    Horsmans, Yves
    Francque, Sven
    Leclercq, Isabelle
    JOURNAL OF HEPATOLOGY, 2020, 73 : S92 - S92
  • [29] Is NASH Related HCC Different From HCC Related to Other Causes
    Dhanasekaran, Renumathy
    Yang, Ju Dong
    Giama, Nasra H.
    Slettedahl, Seth W.
    Harmsen, William S.
    Therneau, Terry
    Kim, W. Ray
    Roberts, Lewis R.
    GASTROENTEROLOGY, 2013, 144 (05) : S1038 - S1038
  • [30] Non-Alcoholic Steatohepatitis (NASH) as a Risk Factor in Hepatocellular Carcinoma (HCC) Development
    Clark, Samantha
    Zuk, Eric
    Kim, Yestle
    Gish, Robert
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 563 - 563
12345